Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative SIFI Block for Positioning Analgesia in Hip Fracture Patients
NCT07556614Phase 4Completed
- Sponsor
- Ghurki Trust and Teaching Hospital
- Start
- Jun 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine in hip fracture (2 arms), sponsored by Ghurki Trust and Teaching Hospital. Primary endpoint: Visual Analogue Scale at 24 hours. Started Jun 2025; status: completed.
02
Drugs
bupivacaine
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT07556614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07556614.